Advanced Solid Malignancies

Showing 26 - 49 of 49

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Malignancies Trial in Seoul (Docetaxel-PNP)

Completed
  • Advanced Solid Malignancies
  • Seoul, Korea, Republic of
    Asan Medical Center
May 2, 2017

Advanced Solid Malignancies, Breast Cancer - ER+, HER2 -, Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation Trial in United

Completed
  • Advanced Solid Malignancies
  • +2 more
  • AZD8835
  • AZD8835 in combination with fulvestrant
  • Denver, Colorado
  • +8 more
Oct 7, 2016

Cancer, Advanced Solid Malignancies Trial in Chuo-ku, Nagoya-shi, Sapporo-shi (AZD4547)

Completed
  • Cancer
  • Advanced Solid Malignancies
  • Chuo-ku, Japan
  • +2 more
Jun 28, 2016

Advanced Solid Malignancies Trial in Manchester, Sutton (AZD2014)

Completed
  • Advanced Solid Malignancies
  • Manchester, United Kingdom
  • +1 more
Jan 13, 2016

Advanced Solid Malignancies, Malignant Lymphoma Trial in Chuo-ku, Manchester, Surrey (AZD1208)

Completed
  • Advanced Solid Malignancies
  • Malignant Lymphoma
  • Chuo-ku, Japan
  • +2 more
Oct 6, 2015

Cancer, Advanced Solid Malignancies Trial in Matsuyama (MEDI-573)

Completed
  • Cancer
  • Advanced Solid Malignancies
  • Matsuyama, Ehime, Japan
    Research Site
Dec 10, 2014

Advanced Solid Malignancies Trial in United States (REGN421(SAR153192))

Completed
  • Advanced Solid Malignancies
  • Aurora, Colorado
  • +7 more
Mar 24, 2014

Advanced Solid Malignancies Trial in Seoul (HM781-36B tablets)

Completed
  • Advanced Solid Malignancies
  • HM781-36B tablets
  • Seoul, Korea, Republic of
    Seoul National University Hospital
May 22, 2013

Advanced Solid Malignancies Trial in Seoul (HM30181AK tablet + Irinotecan tablets)

Completed
  • Advanced Solid Malignancies
  • HM30181AK tablet + Irinotecan tablets
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 4, 2013

Advanced Solid Malignancies Trial in Berlin, Moscow, St. Petersburg (AZD8931)

Completed
  • Advanced Solid Malignancies
  • Berlin, Germany
  • +2 more
Mar 11, 2013

Advanced Solid Malignancies Trial in Japan (MEDI-575)

Completed
  • Advanced Solid Malignancies
  • Nagoya, Aichi, Japan
  • +4 more
Feb 5, 2013

Solid Tumour, Advanced Solid Malignancies, Child-Pugh A to B7 Advanced Hepatocellular Carcinoma Trial in Seoul (AZD1480 Daily,

Terminated
  • Solid Tumour
  • +5 more
  • AZD1480 Daily
  • AZD1480 BID
  • Seoul, Korea, Republic of
    Research Site
Jan 7, 2013

Advanced Solid Malignancies Trial in Seoul (HM30181AK tablet + Irinotecan tablets)

Completed
  • Advanced Solid Malignancies
  • HM30181AK tablet + Irinotecan tablets
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 5, 2011

Advanced Solid Malignancies Trial in Beijing, Hong Kong (cediranib (RECENTIN TM, AZD2171))

Completed
  • Advanced Solid Malignancies
  • cediranib (RECENTIN TM, AZD2171)
  • Beijing, Beijing, China
  • +1 more
Jun 17, 2011

Cancer, Solid Tumors, Advanced Solid Malignancies Trial in Tokyo (AZD8055)

Completed
  • Cancer
  • +2 more
  • Tokyo, Japan
    Research Site
Jun 14, 2011

Advanced Solid Malignancies Trial in Shanghai (ZD4054 (Zibotentan))

Completed
  • Advanced Solid Malignancies
  • ZD4054 (Zibotentan)
  • Shanghai, Shanghai, China
    Research Site
May 18, 2011

Cancer, Solid Tumors, Advanced Solid Malignancies Trial in Minami-ku (AZD7762, gemcitabine)

Terminated
  • Cancer
  • +2 more
  • Minami-ku, Fukuoka, Japan
    Research Site
Feb 4, 2011

Advanced Solid Malignancies Trial in Rochester (Topotecan)

Completed
  • Advanced Solid Malignancies
  • Rochester, Minnesota
    Mayo Clinic
Jan 12, 2011

AUY922A, an HSP90 Inhibitor

Unknown status
  • Advanced Solid Malignancies
    • Sutton, Surrey, United Kingdom
      Royal Marsden NHS Foundation Trust
    Dec 1, 2009

    Advanced Solid Malignancies Trial in Canada, United States (BMS-663513)

    Terminated
    • Advanced Solid Malignancies
    • Philadelphia, Pennsylvania
    • +4 more
    Sep 3, 2009

    Advanced Solid Malignancies Trial in Tokyo (KU-0059436 (AZD2281)(PARP inhibitor))

    Completed
    • Advanced Solid Malignancies
    • KU-0059436 (AZD2281)(PARP inhibitor)
    • Tokyo, Japan
      Research Site
    Aug 19, 2009